BT PHARMA is a Limited Company under French law (Société Anonyme). It is managed by an Executive Management Board (Directoire). The Executive Management Board is controlled by a Supervisory Board of Directors (Conseil de Surveillance) appointed by the General Assembly of shareholders.
Since its creation in 2001, the company has raised a total of € 9.3 million of which € 5.9 million in equity. Main shareholders include founders, business angels, Institut Pasteur, FAM-Midi-Pyrénées and Edmond de Rothschild Investment Partners (EdRIP).
